According to GuruFocus Insider Data, the largest insider sells over the past week were: Electronic Arts Inc, Alexion Pharmaceuticals, American Airlines Group Inc, and Thermo Fisher Scientific Inc.
The overall trend of insiders is illustrated in the chart below:
Electronic Arts, Inc. (EA, Financial): Director Jay C Hoag sold 1,463,159 Shares
Director Jay C Hoag sold 1,463,159 shares of EA stock on Feb. 6 at the average price of $26.4. Jay C Hoag owns at least 9,947,829 shares after this. The price of the stock has increased by 3.11% since.
Electronic Arts,a Delaware corporation was incorporated in 1982. Electronic Arts has a market cap of $8.42 billion; its shares were traded at around $27.22 with a P/E ratio of 38.80 and P/S ratio of 2.23.
Electronic Arts Inc. has released its third quarter 2014 results ended December 31, 2013. GAAP total net revenues were $808 million versus $922 million in the prior year quarter. Non-GAAP revenues were $1.57 billion compared to $1.18 billion last year. Non-GAAP net income was $398 million compared to $176 million last year, but GAAP net loss was $308 million compared to a loss of $45 million a year ago.
VP, Chief Accounting Officer Kenneth A Barker sold 50,000 shares of EA stock on Feb. 7 at the average price of $26.79. EVP, HR & Corporate Services Gabrielle B Toledano sold 55,000 shares of EA stock on Jan. 31 at the average price of $26.01.
Alexion Pharmaceuticals, Inc. (ALXN, Financial): Director Larry Mathis sold 80,729 Shares
Director Larry Mathis sold 80,729 shares of ALXN stock on Feb. 3 at the average price of $157.5. Larry Mathis owns at least 29,456 shares after this. The price of the stock has increased by 3.89% since.
Alexion Pharmaceuticals is a Delaware based company incorporated in 1992 is a biopharmaceutical company serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals, Inc. has a market cap of $32.08 billion; its shares were traded at around $163.63 with a P/E ratio of 92.80 and P/S ratio of 22.89. Alexion Pharmaceuticals had an annual average earnings growth of 68.50% over the past 5 years.
Alexion Pharmaceuticals has released its fourth quarter 2013 results. 2013 net sales increased 37% to $1.55 billion, compared to $1.13 billion last year. GAAP net income was $252.9 million ($1.27 per share) compared to $254.8 million ($1.28 per share) last year.
CEO Leonard Bell sold 11,790 shares of ALXN stock on Feb. 4 at the average price of $154.5. EVP & CFO Vikas Sinha and multiple other insiders have also sold shares of ALXN stock over the past week.
American Airlines Group Inc (AAL, Financial): COO Robert D Isom Jr sold 380,557 Shares
COO Robert D Isom Jr sold 380,557 shares of AAL stock on Jan.31 at the average price of $33.4. Robert D Isom Jr owns at least 518,058 shares after this. The price of the stock has increased by 6.8% since.
AMR Corp was incorporated in October 1982 and operates in the airline industry. American Airlines Group Inc has a market cap of $12.73 billion; its shares were traded at around $35.67 with and P/S ratio of 0.53.
American Airlines Group Inc. posted a fourth quarter net loss of $1.9 billion, combining American Airlines and US Airways Group as a result of the merger closed December 9, 2013.
Thermo Fisher Scientific Inc (TMO, Financial): Sr. VP & CFO Peter M Wilver sold 91,897 Shares
Sr. VP & CFO Peter M Wilver sold 91,897 shares of TMO stock on Feb. at the average price of $115.21. Peter M Wilver owns at least 104,305 shares after this. The price of the stock has increased by 2.22% since.
Thermo Fisher Scientific is a Delaware corporation and was incorporated in 1956. Thermo Fisher Scientific Inc has a market cap of $42.56 billion; its shares were traded at around $117.77 with a P/E ratio of 32.80 and P/S ratio of 3.32. The dividend yield of Thermo Fisher Scientific Inc stocks is 0.51%. Thermo Fisher Scientific Inc had an annual average earnings growth of 16.60% over the past 10 years. GuruFocus rated Thermo Fisher Scientific Inc the business predictability rank of 4.5-star.
The company has released its fourth quarter 2013 results. Adjusted EPS grew 5% to $1.43, and revenue for the quarter grew 6% to $3.47 billion. GAAP diluted EPS for the fourth quarter was $0.92 versus $1.04 a year ago.
Director Jim P Manzi and multiple other insiders have all sold shares of TMO stock over the past week.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
